6515--Diagnostic radiotracer ito visualize the beta amyloid protein in Alzheimer patients.
ID: 36C26225Q0264Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF262-NETWORK CONTRACT OFFICE 22 (36C262)Gilbert, AZ, 85297, USA

NAICS

Surgical and Medical Instrument Manufacturing (339112)

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)

Original Source

https://sam.gov/opp/8066a5606f054283905aea160d64b915/view
Timeline
    Description

    The Department of Veterans Affairs is seeking potential suppliers for a diagnostic radiotracer, specifically the 18-Florbetaben radioisotope, intended for PET imaging in Alzheimer's disease patients. This procurement aims to gather information on the capabilities and classifications of companies that can provide this radiopharmaceutical, which must comply with health and safety regulations and be delivered in a ready-to-use liquid form with necessary bar-code labels. The successful provision of this product is crucial for enhancing the quality of healthcare services offered to Veterans. Interested parties must submit their responses by December 23, 2024, via email to the contracting officer, Debby Abraham, at debby.abraham@va.gov.

    Point(s) of Contact
    DEBBY ABRAHAMCONTRACTING OFFICER
    (562) 766-2234
    DEBBY.ABRAHAM@VA.GOV
    Files
    Title
    Posted
    RFI 36C26225Q0264 Diagnostic radiotracer .pdf
    The Department of Veterans Affairs (VA) has issued a Sources Sought Notice seeking potential suppliers of 18-Florbetaben radioisotope for PET imaging specific to Alzheimer's disease. This request, identified by solicitation number 36C26225Q0264, aims to gather information on the capabilities and size classifications of companies interested in providing this radiopharmaceutical. Responses will aid in future acquisition decisions but do not constitute a formal solicitation. The 18-Florbetaben product must comply with various health and safety regulations and be delivered in liquid form, ready for use with necessary bar-code labels. Key requirements include quality control, safety compliance, technical support for medical staff, and adequate packaging for radioactive materials. Additionally, bidders are required to provide details about their business classification, the ability to meet specifications, and compliance with the Buy American Act. Responses are due by December 23, 2024, and should be sent via email to the designated contracting officer, Debby Abraham. The document serves as a foundational step in the procurement process, emphasizing the VA’s focus on fostering competitive bidding while ensuring high-quality medical supplies for Veterans’ healthcare services.
    Similar Opportunities
    6550--Lab Supplies - (Radiopharm) |
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking vendors to provide Radiopharmaceutical I-123 Ioflupane (DaTscan) for the Philadelphia Veterans Affairs Medical Center. This Sources Sought Notice (Solicitation Number: 36C24425I0218) aims to gather information on suppliers' capabilities, including their DUNS Number and compliance with regulatory standards set by the Nuclear Regulatory Commission and FDA, to ensure timely delivery of essential radiopharmaceuticals for imaging services related to parkinsonian syndrome assessment. Interested vendors must be able to meet key delivery requirements, including next-day delivery during work hours and emergency deliveries within 45 minutes, with responses due by December 27, 2024. For further inquiries, vendors can contact Contracting Officer Amanda Saunders at amanda.saunders@va.gov or (412) 822-3731.
    6505--Pylarify
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to enter into a sole source contract with Lantheus Holdings Inc. for the procurement of Pylarify (Piflufolastat) F-18 PSMA, a specialized radiopharmaceutical product essential for imaging in prostate cancer diagnosis. This contract, managed by the Networking Contracting Office in Newington, CT, aims to support the VA Boston Healthcare System's West Roxbury and Jamaica Plain campuses by ensuring timely delivery of USDA and USP approved radiopharmaceuticals, compliant with Nuclear Regulatory Commission licensing requirements. Interested parties that believe they can fulfill this requirement must submit their capabilities in writing by December 27, 2024, to the designated contracting specialist, Jerry Choinski, at jerry.choinski@va.gov. This notice serves as an expression of intent rather than a formal solicitation, and the government retains discretion over whether to open this procurement for competition based on the responses received.
    6505--Carbidopa/Levodopa SA Tablet
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) 36E79725R0008 for the procurement of Carbidopa/Levodopa sustained release (SA) tablets, aimed at ensuring a continuous supply of these medications for various federal health services, including the Department of Defense and the Bureau of Prisons. The contract will be awarded for an initial period of one year, with the option to extend for four additional one-year periods, requiring offerors to provide unique branding and packaging without overlapping labels. The estimated annual usage totals approximately 119,875 bottles across two dosage forms, highlighting the importance of these medications in treating Parkinson's disease and related conditions. Interested parties should note that the electronic solicitation is expected to be issued around January 3, 2026, with offers due by January 17, 2026; questions can be directed to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov.
    6515--36C261-25-AP-0840 Thyroid Captus 4000e System
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of a Nuclear Medicine Thyroid Uptake System, specifically targeting service-disabled veteran-owned small businesses (SDVOSB). The system is designed to measure radioactive tracer absorption in the thyroid, which is crucial for diagnosing thyroid-related health issues, and must include features such as DICOM compatibility, automated quality assurance, and customizable reporting capabilities. This acquisition aims to enhance diagnostic tools within the VA healthcare system while promoting veteran entrepreneurship, with proposals due by the specified closing date. Interested vendors should contact Contract Specialist Edward B. Hunter at Edward.Hunter@va.gov for further details and to ensure compliance with all submission requirements.
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Abiraterone Acetate Tablets through its Pharmaceutical Prime Vendor Program. Offerors are required to comply with the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP), providing a unique 11-digit National Drug Code (NDC) for each drug, along with pricing for the base year and four optional years, including a Cost Recovery Fee. This procurement is crucial for ensuring consistent availability and competitive pricing of essential medications for federal healthcare users, particularly veterans. Interested parties must submit their proposals by the extended deadline of January 8, 2025, at 2:30 PM CST, and can contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further information.
    6509--Warfarin Tablets (VA-25-00012328)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the supply of Warfarin NA tablets under solicitation number VA-25-00012328. The objective of this procurement is to establish a reliable supply contract for Warfarin tablets to ensure consistent availability and pricing through the VA and Department of Defense's Pharmaceutical Prime Vendor Programs. This initiative is crucial for maintaining a steady supply of essential pharmaceuticals, thereby supporting the government’s commitment to high-quality patient care and regulatory compliance. Interested offerors must submit their proposals by December 31, 2024, at 2:30 PM CST, and should direct any inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    Q522--PET/CT System Lease (523)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the lease of a Siemens MAGNETOM Aera 1.5T MRI Scanner Mobile Unit, along with the provision of an MRI technologist and assistant, to support the Northampton VA Medical Center's imaging needs. This procurement encompasses a firm-fixed contract with a base period of six months, starting January 13, 2025, and includes an optional three-month extension, ensuring comprehensive delivery, setup, preventative maintenance, and emergency repair services for the mobile unit. The initiative underscores the government's commitment to delivering high-quality healthcare services to veterans, with a contract value estimated at approximately $19 million. Interested contractors should reach out to Contract Specialist Divianna N Mathurin at Divianna.Mathurin@va.gov for further details and to ensure compliance with the solicitation requirements.
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Cyclobenzaprine HCL Tablets under solicitation number 36E79725R0009. This unrestricted procurement aims to secure a reliable supply of these essential pharmaceuticals for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC), reflecting the government's commitment to providing necessary medications to veterans and associated healthcare systems. The contract will have an initial duration of one year, with the possibility of four additional one-year extensions, and interested vendors must provide specific drug labeling along with a unique National Drug Code (NDC). The RFP is expected to be released electronically around December 20, 2024, with a submission deadline set for January 3, 2025. For further inquiries, interested parties can contact Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0095 770-25-1-801-0132 -National CMOP FERROUS SULFATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to fulfill an emergency procurement for Ferrous Sulfate 324 mg EC Tablets, with a total quantity of 24,000 tablets to be delivered to multiple CMOP locations. The procurement requires compliance with the Drug Supply Chain Security Act (DSCSA) and mandates that all products be bar-coded according to industry standards, ensuring safety and traceability. This solicitation underscores the VA's commitment to providing quality pharmaceutical supplies for its healthcare services, with a submission deadline for quotes set for December 30, 2024, at 9:00 AM CST. Interested vendors must submit their proposals, including a signed SF1449, an Excel price schedule, and a state wholesale distributor license, to the primary contact, Michael W McAlhaney, at Michael.McAlhaney@va.gov.